A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.

Although a liquid biopsy of circulating tumor cells has been validated and approved by the FDA as a useful prognostic method for various types of cancer, its clinical implementation is not yet widespread.

Bioon's 2018 Forum on Liquid Biopsy Novel Technology and Clinical Application will focus on research of novel technologies. Domestic and foreign experts, clinicians as well as personnels from testing laboratories and high- & new-tech companies will be invited to discussions, to provide all attendees with front-edge technologies, promising projects, to promote exchanges and cooperations in this field.

This forum is one of the top-ranked meetings in the field of biological and medical nanomaterials in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of liquid biopsy in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!